FDA limits Johnson & Johnson vaccine; New York City not ruling out return of mask mandates

Australia News News

FDA limits Johnson & Johnson vaccine; New York City not ruling out return of mask mandates
Australia Latest News,Australia Headlines
  • 📰 ABC7NY
  • ⏱ Reading Time:
  • 47 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 22%
  • Publisher: 51%

There are growing concerns as new data shows hospitalizations and deaths from COVID are tracking higher for the first time in months.

The FDA said Thursday that the one-shot Johnson & Johnson vaccine should only be given to those who either don't have access to the Moderna or Pfizer vaccines or request only the J & J shot.

The recommendation was made after reports of rarely occurring but life-threatening blood clots that have appeared in the days or weeks after some have received the Johnson & Johnson shot., the health commissioner says the city is not ruling out the return of indoor mask mandates. "Right now is the time, as we've moved into medium risk, where we're really encouraging New Yorkers to take more additional steps and use the myriad of tools that we have to manage their own risks, and also to manage the risk of those around them," said Dr. Ashwin Vasan, NYC Health Commissioner."We're also looking at our policies and seeing when we may want to bring back citywide policies, but now is not that time."Right now, New Jersey has an alarming 13.

New York topped more than 10,000 cases a day for the first time in months, but that does not include the many who are testing positive at home.

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

ABC7NY /  🏆 592. in US

Australia Latest News, Australia Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

FDA puts new limits on Johnson & Johnson vaccine due to rare blood clotting conditionFDA puts new limits on Johnson & Johnson vaccine due to rare blood clotting conditionThe FDA revised its emergency authorization to sharply limit the use of Johnson & Johnson's COVID-19 vaccine due to a rare but potentially fatal blood clotting condition called thrombosis with thrombocytopenia syndrome (TTS).
Read more »

FDA announces limits on who can receive Johnson & Johnson COVID-19 vaccineFDA announces limits on who can receive Johnson & Johnson COVID-19 vaccineThe reason is a rare, but serious risk of blood clots.
Read more »

FDA restricts Johnson & Johnson COVID-19 vaccine due to blood clot riskFDA restricts Johnson & Johnson COVID-19 vaccine due to blood clot riskThe Food and Drug Administration said the shot should only be given to adults who cannot receive a different vaccine or specifically request J&J's vaccine.
Read more »

FDA restricts use of Johnson & Johnson COVID vaccine due to blood clot riskFDA restricts use of Johnson & Johnson COVID vaccine due to blood clot riskThe Food and Drug Administration put rigid limits on who can receive Johnson & Johnson’s one-dose COVID-19 vaccine on Thursday, saying the vaccine should only be given to people who cannot receive a different vaccine or those who specifically request it.
Read more »

FDA puts strict limits on Johnson & Johnson Covid-19 vaccineFDA puts strict limits on Johnson & Johnson Covid-19 vaccineThe US Food and Drug Administration announced Thursday that it is limiting the emergency use authorization of the Johnson & Johnson/Janssen Covid-19 vaccine to people 18 and older for whom other vaccines aren't appropriate or accessible and those who opt for J&J because they wouldn't otherwise get vaccinated.
Read more »



Render Time: 2025-02-27 02:01:32